Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing

Abstract

Therapeutic genome engineering relies on the development of reliable, robust and versatile tools. Here the authors develop Cas9-Cas9 chimeras with high target site activity that generate predictable deletions.